Analysis of dysphagia in advanced-stage head-and-neck cancer patients: impact on quality of life and development of a preventive swallowing treatment
- PMID: 29978259
- DOI: 10.1007/s00405-018-5054-9
Analysis of dysphagia in advanced-stage head-and-neck cancer patients: impact on quality of life and development of a preventive swallowing treatment
Abstract
Objectives: Swallowing and voice dysfunctions are common side effects following head-and-neck squamous-cell carcinoma (HNSCC) treatment. Our aim was to analyze the relationships between quality of life, swallowing, and phonatory problems in patients with an advanced-stage HNSCC and to prospectively evaluate the effects of a prophylactic swallowing program.
Methods: First, we retrospectively studied 60 advanced HNSCC patients treated with exclusive or adjuvant radiotherapy/chemoradiotherapy (RT/CRT). Subjects were classified according to general and clinical-therapeutic features. Outcome measures included EORTC QLQ-C30, EORTC QLQ-H&N35, Dysphagia Handicap Index (DHI), M.D.Anderson Dysphagia Inventory (MDADI), and Voice Handicap Index (VHI). Then, we conducted a prospective evaluation of a prophylactic swallowing counselling in 12 consecutive advanced-stage HNSCC patients by a two-arm case-control analysis. These patients were treated with exclusive or adjuvant RT/CRT.
Results: 71% of the retrospective population studied reported swallowing dysfunction as a major side effect. No differences were detected in the severity of dysphagia or dysphonia according to type of treatment or staging of the primary tumour, while hypopharyngeal and laryngeal cancer patients showed significantly better swallowing ability and better QoL compared to oral cavity and oropharyngeal localisation (p < 0.05). In addition, a relevant correlation between swallowing and voice problems emerged (p < 0.05). In the prospective part, while no statistical correlation was evident before the start of RT/CRT in the experimental group compared to the control one, the former showed better performances at MDADI (p = 0.006) and DHI (p = 0.002) test 3 months after its end.
Conclusion: Dysphagia is both an acute-and-long-term side effect which greatly affects QoL of HNSCC patients undergoing multimodality treatment. Our data show that a prophylactic swallowing program could actually produce a beneficial effect on patients' outcomes.
Level of evidence: 1b and 2b.
Keywords: Dysphagia; Head-and-neck cancer patients; Quality of life; Swallowing exercises; Swallowing preservation.
Similar articles
-
Subjective and perceptive assessment of speech/voice and swallowing function before and after radiation therapy in patients of head-and-neck squamous cell cancer.J Cancer Res Ther. 2023 Apr;19(Supplement):S0. doi: 10.4103/jcrt.jcrt_621_21. J Cancer Res Ther. 2023. PMID: 37147961
-
Prospective clinical study on long-term swallowing function and voice quality in advanced head and neck cancer patients treated with concurrent chemoradiotherapy and preventive swallowing exercises.Eur Arch Otorhinolaryngol. 2015 Nov;272(11):3521-31. doi: 10.1007/s00405-014-3379-6. Epub 2014 Nov 8. Eur Arch Otorhinolaryngol. 2015. PMID: 25381096 Clinical Trial.
-
Effects of prophylactic swallowing exercises on dysphagia and quality of life in patients with head and neck cancer receiving (chemo) radiotherapy: the Redyor study, a protocol for a randomized clinical trial.Trials. 2019 Aug 14;20(1):503. doi: 10.1186/s13063-019-3587-x. Trials. 2019. PMID: 31412947 Free PMC article.
-
Evaluation and management of oropharyngeal Dysphagia in head and neck cancer.Cancer Control. 2002 Sep-Oct;9(5):400-9. doi: 10.1177/107327480200900505. Cancer Control. 2002. PMID: 12410179 Review.
-
Dysphagia following chemoradiation for locally advanced head and neck cancer.Ann Oncol. 2004 Mar;15(3):383-8. doi: 10.1093/annonc/mdh101. Ann Oncol. 2004. PMID: 14998839 Review.
Cited by
-
A randomized controlled study evaluating the head-lift exercise in head and neck cancer patients with radiation-induced dysphagia: effect on swallowing function and health-related quality of life over 12 months.Eur Arch Otorhinolaryngol. 2023 Dec;280(12):5445-5457. doi: 10.1007/s00405-023-08183-7. Epub 2023 Aug 16. Eur Arch Otorhinolaryngol. 2023. PMID: 37584752 Free PMC article. Clinical Trial.
-
Dose in Exercise-Based Dysphagia Therapies: A Scoping Review.Dysphagia. 2021 Feb;36(1):1-32. doi: 10.1007/s00455-020-10104-3. Epub 2020 Mar 5. Dysphagia. 2021. PMID: 32140905 Free PMC article.
-
Efficacy and Safety of Iodine-125 Brachytherapy in the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.Onco Targets Ther. 2020 Sep 29;13:9657-9666. doi: 10.2147/OTT.S269626. eCollection 2020. Onco Targets Ther. 2020. PMID: 33061447 Free PMC article.
-
Perioperative change trajectories and predictors of swallowing function and swallowing-related quality of life in patients with oral cancer: a longitudinal observational study.BMJ Open. 2023 Dec 12;13(12):e075401. doi: 10.1136/bmjopen-2023-075401. BMJ Open. 2023. PMID: 38086600 Free PMC article.
-
Pentoxifylline and vitamin E reduce the severity of radiotherapy-induced oral mucositis and dysphagia in head and neck cancer patients: a randomized, controlled study.Med Oncol. 2019 Nov 21;37(1):8. doi: 10.1007/s12032-019-1334-5. Med Oncol. 2019. PMID: 31748905 Clinical Trial.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials